SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from NRX Pharmaceuticals, Inc. (NRXP) (CIK 0001719406) (NRXP) — Nov 16, 2017

NRX Pharmaceuticals, Inc. (NRXP) (CIK 0001719406)
Date: Nov. 16, 2017 · CIK: 0001719406 · Accession: 0001654954-17-010788

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-220947

Date
Nov. 16, 2017
Author
EARLYBIRDCAPITAL
Form
CORRESP
Company
NRX Pharmaceuticals, Inc. (NRXP) (CIK 0001719406)

Letter

VIA EDGAR Securities and Exchange Commission Re: Big Rock Partners Acquisition Corp. (the "Company") Registration Statement on Form S-1 (File No. 333-220947) (the "Registration Statement")

Dear Ms. Ravitz:

In accordance with the provisions of Rule 460 under the Securities Act of 1933, the undersigned, as representative of the underwriters of the proposed offering of securities of Big Rock Partners Acquisition Corp., hereby advises that copies of the Preliminary Prospectus, dated November 14, 2017, were distributed on or about November 14, 2017, as follows:

235 to individual investors;

108 to FINRA members (which included 28 prospective underwriters and selected dealers); and

49 to institutions.

The undersigned has been informed by the participating dealers that, in accordance with Rule 15c2-8 under the Securities Exchange Act of 1934, copies of the Preliminary Prospectus, dated November 14, 2017, have been distributed to all persons to whom it is expected that confirmations of sale will be sent; and we have likewise so distributed copies to all customers of ours. We have adequate equity to underwrite a “firm commitment” offering.

Very truly
yours,
EARLYBIRDCAPITAL,
INC.

Show Raw Text
CORRESP
1
filename1.htm

Blueprint

EARLYBIRDCAPITAL, INC.

366 Madison Avenue | 8th Floor

New York, NY 10017

November 16,
2017

VIA EDGAR

Securities
and Exchange Commission

100 F.
Street, N.E.

Washington,
D.C. 20549

Attn:
Amanda Ravitz

Re:

Big Rock Partners Acquisition Corp. (the "Company")

Registration Statement on Form S-1

(File No. 333-220947) (the "Registration Statement")

Dear
Ms. Ravitz:

In
accordance with the provisions of Rule 460 under the Securities Act
of 1933, the undersigned, as representative of the underwriters of
the proposed offering of securities of Big Rock Partners
Acquisition Corp., hereby advises that copies of the Preliminary
Prospectus, dated November 14, 2017, were distributed on or about
November 14, 2017, as follows:

235 to
individual investors;

108 to
FINRA members (which included 28 prospective underwriters and
selected dealers); and

49 to
institutions.

The
undersigned has been informed by the participating dealers that, in
accordance with Rule 15c2-8 under the Securities Exchange Act of
1934, copies of the Preliminary Prospectus, dated November 14,
2017, have been distributed to all persons to whom it is expected
that confirmations of sale will be sent; and we have likewise so
distributed copies to all customers of ours. We have adequate
equity to underwrite a “firm commitment”
offering.

Very truly
yours,

EARLYBIRDCAPITAL,
INC.

By:

/s/
Steven
Levine

Name:

Steven
Levine

Title:

CEO